Trimethoprim-sulfamethoxazole in the treatment of gynecological tract infections

• Autores: Ludmir Grimberg, Abraham, Román Loayza, Carlos, Guevara, José
• Formato: artículo
• Fecha de Publicación: 2015
• Institución: Sociedad Peruana de Obstetricia y Ginecología
• Repositorio: Revista SPOG - Revista Peruana de Ginecología y Obstetricia
• Lenguaje: español
• OAI Identifier: oai:ojs.spog:article/747
• Enlace del recurso: http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/747
• Nivel de acceso: acceso abierto

This work was performed in 61 patients with ginecológic tract infection, of which 51 received trimethoprim-sulfamethoxazole association at doses of 320 mg. and 16 gr. and 10 patients respectively as a comparative group received ampicillin 2 g. / day. In addition, 10 patients without morbidity postpartum received chemotherapeutic aforesaid association at the same doses, which serves as a control group. Treatment duration was 7 days; haematological and bacteriological studies were performed before and after treatment, discussing the results. In the group receiving morbid trimethoprim-sulfamethoxazole a clinical cure is observed in 42 cases (82.3%), of which 38 cases persistence of positive cultures was evident and in 9 cases (17.7%) with unfavorable clinical outcome. In the group that received ampicillin observed 8 cases (80%) with clinical cure of which 6 cases persisted positive culture and in 2 cases (20%) with unfavorable clinical course. In the group of patients not morbid 9 positive and 1 negative cultures found.